Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

352
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
352
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

275
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
275
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

227
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
227
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

268
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
268
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

294
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
294
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

395
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
395

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Zygosity and autonomic stress reactivity during social exclusion: biofeedback findings from the TwinCord-EDID study.

Frontiers in psychiatry·2026
Same author

Links between personality functioning and post-traumatic stress disorder symptoms: a network analysis.

European journal of psychotraumatology·2026
Same author

Chronic activity-based anorexia alters food intake microstructure in a time-dependent manner in female rats.

Physiology & behavior·2026
Same author

How personality functioning shapes symptom development during and after treatment: A random intercept cross lagged panel analysis.

Comprehensive psychiatry·2026
Same author

Long-Term Effectiveness of Inpatient and Day-Hospital Treatment of Eating Disorders in Departments of Psychosomatic Medicine and Psychotherapy in Germany.

European eating disorders review : the journal of the Eating Disorders Association·2026
Same author

A longitudinal bifactor approach to modelling somatic symptom development in psychosomatic treatment.

Journal of psychosomatic research·2026

Related Experiment Video

Updated: Aug 25, 2025

Functional Near-Infrared Spectroscopy Hyperscanning Study in Psychological Counseling
06:04

Functional Near-Infrared Spectroscopy Hyperscanning Study in Psychological Counseling

Published on: January 17, 2025

694

[Hypnotherapy for Irritable Bowel Syndrome].

Marissa Bentele, Andreas Stengel

    Psychotherapie, Psychosomatik, Medizinische Psychologie
    |October 18, 2022
    PubMed
    Summary

    Irritable bowel syndrome (IBS) is a common digestive disorder. Gut-directed hypnosis is a proven psychotherapeutic intervention that effectively manages IBS symptoms and enhances patient quality of life.

    Area of Science:

    • Gastroenterology
    • Psychiatry
    • Psychotherapy

    Context:

    • Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder.
    • The biopsychosocial model guides IBS management.
    • Therapeutic interventions aim to alleviate symptoms and improve quality of life.

    Purpose:

    • To highlight gut-directed hypnosis as a viable psychotherapeutic intervention for IBS.
    • To underscore the empirical evidence supporting its efficacy.

    Summary:

    • Gut-directed hypnosis is a specialized form of hypnotherapy.
    • It is recognized for its significant empirical evidence in managing IBS.
    • This intervention aligns with the biopsychosocial approach to functional disorders.

    More Related Videos

    Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
    10:37

    Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform

    Published on: November 30, 2016

    8.4K
    Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation
    04:04

    Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation

    Published on: July 5, 2024

    524

    Related Experiment Videos

    Last Updated: Aug 25, 2025

    Functional Near-Infrared Spectroscopy Hyperscanning Study in Psychological Counseling
    06:04

    Functional Near-Infrared Spectroscopy Hyperscanning Study in Psychological Counseling

    Published on: January 17, 2025

    694
    Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
    10:37

    Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform

    Published on: November 30, 2016

    8.4K
    Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation
    04:04

    Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation

    Published on: July 5, 2024

    524

    Impact:

    • Provides an effective, evidence-based treatment option for IBS patients.
    • Offers a non-pharmacological approach to managing a chronic condition.
    • Improves patient outcomes and quality of life by addressing both physical and psychological aspects of IBS.